|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma's Image Fix: Lessons from the Fieldover 8 years ago
The Innovation Distinction: Biopharma's Reputational Passover 8 years ago
Valeant’s Northern Faceover 8 years ago
More New Drugs and Generics Reshape Pharma Marketsover 8 years ago
Leadership in All the Right Placesover 8 years ago
Industry Engine CheckAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5